Explore News By Topic

02/11/2019

Study finds upsurge in ‘active surveillance’ for low-risk prostate cancer

Original Press Release Issued by: Dana-Farber Cancer Institute Many men with low-risk prostate cancer who most likely previously would have undergone immediate surgery or radiation are now adopting a more conservative “active surveillance” strategy, according to an analysis of a new federal database by scientists from Dana-Farber Cancer Institute. The use... Read More

02/07/2019

Atlanta Hawks, Prostate Cancer Foundation Team Up To Fight Prostate Cancer

ATLANTA – The Atlanta Hawks and Prostate Cancer Foundation (PCF) have joined together to launch a first-of-its-kind multi-pronged program with the goal of slamming prostate cancer. Led by Hawks Vice Chair of the Board and Naismith Memorial Basketball Hall of Famer Grant Hill and his father, NFL Legend Calvin Hill, the Hawks are... Read More

01/31/2019

Fuego Box Turns Up The Heat On Prostate Cancer With The Choco Challenge™

LOS ANGELES - JANUARY 31, 2019 As Valentine’s Day approaches, spice up your life while supporting the fight against prostate cancer. Fuego Box, purveyors of small-batch/craft hot sauces delivered to your door monthly, is teaming up with the Prostate Cancer Foundation (PCF) on The Choco Challenge™, the world’s spiciest mini chocolate bar. People... Read More

12/18/2018

Prostate Cancer Scoring Method May Underestimate Mortality Risk in Black Men

Original Press Release Issued by: Dana-Farber Cancer Institute Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests. This... Read More

11/28/2018

Reliance on ‘YouTube Medicine’ May Be Dangerous for Those Concerned About Prostate Cancer

Original Press Release Issued by: NYU Langone Health NOVEMBER 27, 2018 (9:30AM) The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows. Led by researchers at NYU School of Medicine and NYU... Read More

10/08/2018

Baylor research team awarded $6.3 million NCI grant to develop tools to better understand disparities in prostate, breast cancers

Original Press Release Issued by: Baylor College of Medicine HOUSTON – (Oct. 3, 2018) – As part of the Beau Biden Cancer Moonshot initiative, the National Cancer Institute has awarded $6.3 million dollars to Dr. Nicholas Mitsiades and a multidisciplinary, collaborative team at Baylor College of Medicine to establish a... Read More

10/02/2018

Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca® (rucaparib) for Treatment of BRCA1/2-Mutated Metastatic Castration Resistant Prostate Cancer (mCRPC)

Breakthrough Therapy designation (BTD) granted to Rubraca based on initial data from ongoingTRITON2 Phase 2 study in advanced prostate cancer The data set from the TRITON2 study which supported BTD will be presented at the 2018 ESMO Congress later this month in Munich    BOULDER, Colo. (BUSINESS WIRE) -- October... Read More

10/01/2018

MD Anderson Immunologist Jim Allison Awarded Nobel Prize

Original Press Release issued by: MD Anderson News Jim Allison, Ph.D., chair of Immunology and executive director of the Immunotherapy Platform at The University of Texas MD Anderson Cancer Center, today was awarded the 2018 Nobel Prize in Physiology or Medicine for launching an effective new way to attack cancer by treating the immune system... Read More

09/13/2018

FinditParts Announces First Ever Matching Donation Campaign in Commercial Vehicle Industry to Raise Funds And Awareness for Prostate Cancer Research

LOS ANGELES (Sept. 12, 2018) -- FinditParts, the number one supplier of heavy duty truck and trailer parts online, today pledged its commitment to the Prostate Cancer Foundation’s (PCF) community fundraising initiative, Many vs Cancer, to match 100 percent of donations made through its website beginning in September which is... Read More

09/04/2018

Immunotherapy could offer hope for some men with aggressive prostate cancers

Original Press Release issued by: The Institute of Cancer Research, London Study finds that a subset of men with prostate cancer have ‘mismatch’ DNA repair defects in their tumours These men have very aggressive disease with worse survival on currently available therapies BUT are more likely to benefit from immunotherapy New... Read More